Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine

PURPOSE: A novel nanomedicine, CYT-6091, constructed by simultaneously binding recombinant human tumor necrosis factor alpha (rhTNF) and thiolyated polyethylene glycol to the surface of 27 nm colloidal gold particles, was tested in a phase I dose escalation clinical trial in advanced-stage cancer pa...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Libutti, Steven K., Paciotti, Giulio F., Byrnes, Adriana A., Alexander, H. Richard, Gannon, William E., Walker, Melissa, Seidel, Geoffrey D., Yuldasheva, Nargiza, Tamarkin, Lawrence
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2010
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3004980/
https://ncbi.nlm.nih.gov/pubmed/20876255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-0978
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg